Mexiletine Hydrochloride (AvKARE, Inc.)


Welcome to the PulseAid listing for the Mexiletine Hydrochloride drug offered from AvKARE, Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: Mexiletine Hydrochloride
SUBSTANCE NAME: MEXILETINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-09
END MARKETING DATE: 0000-00-00


Mexiletine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMexiletine Hydrochloride from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2013-07-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-624_b1fbaf51-0752-96de-3790-c7d3b02ea62c
PRODUCT NDC: 42291-624
APPLICATION NUMBER: ANDA074377

Other MEXILETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalMexiletine Hydrochloride
AvKARE, Inc.Mexiletine Hydrochloride
Carilion Materials ManagementMexiletine Hydrochloride
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLCMexiletine Hydrochloride
Teva Pharmaceuticals USA, Inc.Mexiletine Hydrochloride